{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:26:37Z","timestamp":1792074397805,"version":"4.4.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The geriatric population, especially individuals over 65\u202fyears old with comorbidities classified by the ASA (American Society of Anesthesiologists) grading system, requires careful sedation management during flexible bronchoscopy (FB) to reduce the heightened risks of complications. Hypoxemia is a particularly critical concern in this demographic, leading to considerable morbidity, mortality, and increased healthcare costs. This study focuses on comparing the incidence of sedation-related hypoxemia and other adverse events between remimazolam besylate and propofol during FB procedures, aiming to enhance patient safety and optimize sedation practices in this vulnerable population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This prospective observational cohort study compared the incidence of hypoxemia and sedation-related adverse events between remimazolam besylate and propofol in 69 elderly patients (ASA I-III). Rigorous inclusion\/exclusion criteria, clinical monitoring, and alongside comprehensive monitoring of clinical parameters and statistical analyses to ensure the validity of the results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Hypoxemia occurred in 44.90% overall, with significantly lower incidence in remimazolam besylate cohort (29.42% vs. 60.00%; OR\u202f=\u202f2.10, 95% CI 1.18\u20133.74, <jats:italic>p<\/jats:italic>\u202f=\u202f0.017). Recovery to full alertness was prolonged with remimazolam (median 15[12.5\u201320] vs. 8[5.5\u201310] min; <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001). A trend toward reduced hypotension was observed (17.65% vs. 37.14%, <jats:italic>p<\/jats:italic>\u202f=\u202f0.0699), with no other significant safety differences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Remimazolam besylate demonstrates superior safety for elderly FB sedation, significantly reducing hypoxemia risk and accelerating recovery. These findings support its preferential use in geriatric sedation protocols, warranting further investigation to optimize clinical implementation strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1543866","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T12:38:10Z","timestamp":1743165490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of deep sedation effects and respiratory aspects of remimazolam besylate in elderly patients undergoing fiberoptic bronchoscopy"],"prefix":"10.3389","volume":"12","author":[{"given":"Dongmei","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12890-022-02188-4","article-title":"Incidence of oxygen desaturation using a high-flow nasal cannula versus a facemask during flexible bronchoscopy in patients at risk of hypoxemia: a randomised controlled trial","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Pulm Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/s0272-5231(03)00050-9","article-title":"Management of hypoxemia during flexible bronchoscopy","volume":"24","author":"Chhajed","year":"2003","journal-title":"Clin Chest Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.21037\/apm-22-89","article-title":"Up-down determination of the 90% effective dose (ED90) of remimazolam besylate for anesthesia induction","volume":"11","author":"Lu","year":"2022","journal-title":"Ann Palliat Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ibra.12072","article-title":"The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography","volume":"9","author":"Tan","year":"2023","journal-title":"Ibrain"},{"key":"ref5","first-page":"4594","article-title":"The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial","volume":"12","author":"Chen","year":"2020","journal-title":"Am J Transl Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e936580","DOI":"10.12659\/MSM.936580","article-title":"Remimazolam Tosilate sedation with adjuvant Sufentanil in Chinese patients with liver cirrhosis undergoing gastroscopy: a randomized controlled study","volume":"28","author":"Cao","year":"2022","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e15495","DOI":"10.7717\/peerj.15495","article-title":"Remimazolam versus propofol for procedural sedation: a meta-analysis of randomized controlled trials","volume":"11","author":"Chang","year":"2023","journal-title":"PeerJ"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","article-title":"Safety and efficacy of Remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy","volume":"155","author":"Pastis","year":"2019","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","article-title":"A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy","volume":"88","author":"Rex","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jgh.15188","article-title":"Remimazolam tosilate in upper gastrointestinal endoscopy: a multicenter, randomized, non-inferiority, phase III trial","volume":"36","author":"Chen","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","article-title":"Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial","volume":"34","author":"Doi","year":"2020","journal-title":"J Anesth"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"7102293","DOI":"10.1155\/2022\/7102293","article-title":"Efficacy and safety of remimazolam besylate combined with alfentanil in painless gastroscopy: a randomized, single-blind, parallel controlled study","volume":"2022","author":"Xu","year":"2022","journal-title":"Contrast Media Mol Imaging"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijnurstu.2016.05.004","article-title":"Depth of anaesthesia monitoring during procedural sedation and analgesia: a systematic review and meta-analysis","volume":"63","author":"Conway","year":"2016","journal-title":"Int J Nurs Stud"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e018611","DOI":"10.1136\/bmjopen-2017-018611","article-title":"Preoxygenation with non-invasive ventilation versus high-flow nasal cannula oxygen therapy for intubation of patients with acute hypoxaemic respiratory failure in ICU: the prospective randomised controlled FLORALI-2 study protocol","volume":"7","author":"Frat","year":"2017","journal-title":"BMJ Open"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics","volume":"115","author":"Antonik","year":"2012","journal-title":"Anesth Analg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s1078-5337(05)70087-3","article-title":"Mechanisms of hypoxemia","volume":"6","author":"Henig","year":"2000","journal-title":"Respir Care Clin N Am"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.gie.2024.04.001","article-title":"Safety and efficacy of remimazolam versus propofol during EUS: a multicenter randomized controlled study","volume":"100","author":"Choe","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00228-024-03624-6","article-title":"Remimazolam versus propofol for sedation in gastrointestinal endoscopy and colonoscopy within elderly patients: a meta-analysis of randomized controlled trials","volume":"80","author":"Ahmer","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/ACO.0000000000001384","article-title":"Remimazolam: its clinical pharmacology and evolving role in anesthesia and sedation practice","volume":"37","author":"Masui","year":"2024","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/aas.14421","article-title":"The clinical role of remimazolam: protocol for a scoping review","volume":"68","author":"Intzilaki","year":"2024","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/diagnostics12071523","article-title":"Efficacy and safety of deep sedation and anaesthesia for complex endoscopic procedures-a narrative review","volume":"12","author":"Godoroja-Diarto","year":"2022","journal-title":"Diagn Basel Switz"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1111\/jcpt.13797","article-title":"Remimazolam versus propofol for deep sedation\/anaesthesia in upper gastrointestinal endoscopy in elderly patients: a multicenter, randomized controlled trial","volume":"47","author":"Lu","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.21037\/tlcr-21-870","article-title":"Malignant thoracic lymph node classification with deep convolutional neural networks on real-time endobronchial ultrasound (EBUS) images","volume":"11","author":"Yong","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e27176","DOI":"10.1097\/MD.0000000000027176","article-title":"Patient satisfaction with deep versus light\/moderate sedation for non-surgical procedures: a systematic review and meta-analysis","volume":"100","author":"Hoshijima","year":"2021","journal-title":"Medicine"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1543866\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T12:38:21Z","timestamp":1743165501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1543866\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":24,"alternative-id":["10.3389\/fmed.2025.1543866"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1543866","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"article-number":"1543866"}}